Related references
Note: Only part of the references are listed.
Article
Gastroenterology & Hepatology
Lei Chen et al.
Summary: This study investigates the role of acidic bile salts in activating NOTCH signaling in oesophageal adenocarcinoma (EAC). The researchers found that there is a crosstalk between APE1 redox function, reflux-induced inflammation, and DLL1 upregulation, which promotes cancer cell stem-like properties in EAC. The overexpression of APE1 and DLL1 is associated with poor overall survival in EAC patients.
Article
Gastroenterology & Hepatology
Claire A. Beveridge et al.
Summary: This study aimed to assess the rate of visible lesion (VL) detection by academic and community endoscopists using high-definition white-light endoscopy (HD-WLE) and narrow-band imaging (NBI). Participants identified VLs using HD-WLE and NBI, and the results showed that 28% and 31% of VLs were not identified using HD-WLE and NBI respectively. The study also found that the rate of VL detection was associated with the endoscopist's experience and the number of surveillance endoscopies performed each month.
GASTROINTESTINAL ENDOSCOPY
(2023)
Review
Gastroenterology & Hepatology
Shyam Vedantam et al.
Summary: In this study, 9 studies were identified, involving 2356 patients with Lynch syndrome who underwent 7838 upper endoscopy screenings. The results showed that upper GI cancer screening using endoscopy can detect Lynch syndrome-associated upper GI malignancies, high-risk lesions, and other clinically actionable findings, supporting its use as part of cancer risk management in Lynch syndrome.
GASTROINTESTINAL ENDOSCOPY
(2023)
Article
Gastroenterology & Hepatology
Nicholas J. Shaheen et al.
Summary: This study evaluated the risk of progression in different types of Barrett's esophagus (BE) reported by WATS3D, including crypt dysplasia (CD) and low-grade dysplasia (LGD). The results showed that non-dysplastic BE diagnosed by WATS3D had a very low risk of progression, while CD had a significantly higher risk compared to non-dysplastic BE but lower than LGD.
GASTROINTESTINAL ENDOSCOPY
(2022)
Article
Cell Biology
Wladyslaw Januszewicz et al.
Summary: This study assessed the utility of p53 immunohistochemistry in evaluating BE-IND specimens. The results showed that p53-IHC reduced the rate of BE-IND diagnoses and improved the interobserver agreement among pathologists.
Article
Pathology
Olli Helminen et al.
Summary: The aim of this study was to evaluate the value of p53, Ki67, and toll-like receptor 5 (TLR5) in predicting the malignant progression of Barrett's esophagus. It was found that aberrant p53 expression is associated with a high risk of malignant progression in Barrett's low-grade dysplasia. Routine staining of p53 is recommended in expert confirmed low-grade dysplasia cases.
Article
Immunology
Srinand Sundaram et al.
Summary: This study explored the immune dynamics in the progression of esophageal adenocarcinoma and highlighted the potential application of a new multiplex imaging platform combined with computational image analysis on routine clinical FFPE sections to investigate complex immune populations in tumor ecosystems.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Medicine, General & Internal
Francesco Maione et al.
Summary: Barrett's Esophagus is a common condition associated with chronic gastroesophageal reflux disease and has a higher risk of developing esophageal adenocarcinoma. Low and high-grade dysplasia precede neoplastic transformation in this condition. The evaluation of low-grade dysplastic esophageal mucosa is still controversial, but endoscopic surveillance and minimally invasive endoscopic treatments such as endoscopic mucosal resection and radiofrequency ablation are available options. Cryotherapy ablation and argon plasma coagulation are novel endoscopic treatments with high eradication rates and fewer complications and post-procedural pain.
Article
Gastroenterology & Hepatology
Swathi Eluri et al.
Summary: This study found that only 39% of eligible patients for Barrett's esophagus screening underwent upper esophagogastroduodenoscopy (EGD), with most of the examinations being triggered by refractory symptoms. Improved dissemination and implementation of BE screening are needed.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Gastroenterology & Hepatology
Srividya Venkitachalam et al.
Summary: The study suggests that the EphB2 signaling pathway is frequently hyperactivated in the early development of Barrett's esophagus-associated esophageal adenocarcinoma (BE-EAC) and acts as an upstream regulator of the MYC gene. Inhibiting EphB2 can significantly impede the proliferation of BE and EAC cells. Targeting EphB2/MYC could be a promising strategy for treating this common refractory and aggressive cancer.
Article
Gastroenterology & Hepatology
Shahriar Faghani et al.
Summary: A deep learning model was developed to accurately predict the dysplasia grade of Barrett's esophagus (BE) on whole-slide images. The model, using an ensemble approach, demonstrated high sensitivity and specificity for low-grade dysplasia (LGD), non-dysplastic BE (NDBE), and high-grade dysplasia (HGD) diagnoses. The findings of this study are important for improving the histologic diagnosis of BE dysplasia and the appropriate use of endoscopic therapy.
GASTROINTESTINAL ENDOSCOPY
(2022)
Article
Oncology
Shaoming Wang et al.
Summary: A male predominance was observed in esophageal and gastric cancers across the world from 2003 to 2012, with variations in male-to-female incidence rate ratios by age. Further investigation is needed to understand the underlying etiologies of these cancers by histological subtype and subsite.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Multidisciplinary Sciences
Xin Gan et al.
Summary: The value of anti-CTLA-4 antibodies in cancer therapy is well established. However, current anti-CTLA-4 therapeutic antibodies have limitations that hinder their broad application. This study successfully developed HCAb 4003-2, a fully human heavy chain-only antibody, which showed superior antitumor activity compared to ipilimumab and other anti-CTLA-4 antibodies in in vitro and in vivo experiments. HCAb 4003-2 also demonstrated a shorter serum half-life and lower systemic drug exposure. These findings make HCAb 4003-2 a promising candidate for the development of next generation anti-CTLA-4 therapy.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Gastroenterology & Hepatology
Yushi Lin et al.
Summary: The incidence rates of esophageal squamous cell carcinoma (ESCC) have been decreasing worldwide, while the rates of esophageal adenocarcinoma (EAC) have been increasing. Most countries are expected to continue experiencing a decreasing or stable trend in esophageal cancer incidence, except Denmark, the Netherlands, and the UK where the rates of EAC are predicted to increase. The changing patterns of these two subtypes of esophageal cancer may require innovative interventions to address issues such as obesity, GERD, and Barrett's esophagus.
Article
Gastroenterology & Hepatology
Mirjam C. M. van der Ende-van Loon et al.
Summary: The study found that non-dysplastic Barrett's esophagus (NDBE) patients have similar or better health-related quality of life, anxiety, and depression compared to the general population. However, factors such as cancer worry, gastrointestinal symptoms, anxiety and depression, and female gender can influence the negative perception of the diagnosis of Barrett's esophagus.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
(2022)
Article
Oncology
Carlijn A. M. Roumans et al.
Summary: Barrett's esophagus (BE) is the precursor lesion of esophageal adenocarcinoma (EAC). The cost-effectiveness of current surveillance strategies for BE is debatable. This multicenter prospective cohort study aimed to evaluate sex differences in 868 BE patients. The results showed that males had higher risk and shorter time to neoplastic progression, while females were more likely to be diagnosed with (advanced) EAC. These findings can guide the development of sex-specific guidelines and improve neoplastic risk stratification in BE surveillance.
Review
Oncology
Asif Sukri et al.
Summary: Gastric cancer remains a leading cause of cancer-related death in developing countries, while immunotherapy has shown promising results in improving prognosis. Research on the roles of immune cells in gastric cancer pathogenesis is vital for developing effective immunotherapy strategies.
Review
Oncology
Ji-Sun Kim et al.
Summary: This study evaluated the accuracy of artificial intelligence (AI)-assisted discrimination of oral cancerous lesions from normal mucosa based on mucosal images. The results showed that AI-assisted screening had high diagnostic accuracy, especially with optical coherence tomography (OCT). Automated detection of oral cancerous lesions by AI has the potential to be a clinical tool for early diagnosis of oral cancer.
Article
Biochemistry & Molecular Biology
Kai Li et al.
Summary: This study investigated the potential oncogenic role of deubiquitinating enzyme USP45 in pan-cancer. The results showed that USP45 is upregulated in most tumors and negatively correlated with overall survival and recurrence-free survival. USP45 was also found to be closely related to tumor stemness, tumor heterogeneity, and tumor immunity. The study provides new insights for further investigation of USP45.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2022)
Article
Immunology
Kazuya Takahashi et al.
Summary: Patients with peritoneal metastases show decreased proportions of CD8(+) T cells, NKT-like cells, and NK cells, along with increased proportions of B cells and macrophages with enhanced expression of specific markers. These alterations in the immune cell phenotypes in the peritoneal cavity might play a role in the development and progression of intraperitoneal tumor growth.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Oncology
Elona Cekani et al.
Summary: KRAS mutations are common in NSCLC, particularly in lung adenocarcinoma, and were previously not seen as clinically relevant. Recent advancements in the approval of KRAS inhibitors have improved survival in this patient group. New approaches targeting KRAS are also in development to address the clinical aspects of KRAS mutations in NSCLC, including interactions with immune checkpoint inhibitors.
Review
Biochemistry & Molecular Biology
Rita Ribeiro et al.
Summary: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is more common in young pre-menopausal women. This review discusses the implications of TNBC's characteristics, such as its lack of hormone receptors and high tumor mutational burden, for diagnosis, treatment, and prognosis. It highlights the potential of immunotherapy as an alternative treatment for TNBC, including the use of immune gene signatures and tumor-infiltrating lymphocytes as biomarkers. The review also explores different formats of immunotherapy currently under clinical research, such as immune checkpoint inhibitors and antibody-drug conjugates.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2022)
Article
Oncology
Bryan H. Louie et al.
Summary: In a study evaluating the experience of 80 advanced cancer patients, a multidisciplinary Molecular Tumor Board (MTB) was able to develop personalized treatment regimens, including immune checkpoint blockade (ICB), based on tumor molecular characteristics. Patients with high matching scores between tumor molecular characteristics and ICB biomarkers had significantly improved clinical outcomes, including longer progression-free survival and overall survival rates.
NPJ PRECISION ONCOLOGY
(2022)
Article
Gastroenterology & Hepatology
Noam Peleg et al.
Summary: NLR can serve as a predictor for histologic progression in patients with BE, with a high discriminatory capacity for progression to HGD and EAC, especially effective in patients with NDBE.
Article
Biochemistry & Molecular Biology
Liping Wang et al.
Summary: This study found that glutamine deprivation can increase PD-L1 expression and activate the EGFR/MEK/ERK/c-Jun signaling pathway, thereby affecting T cell function.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Article
Pathology
Christopher J. Bowman et al.
Summary: Endoscopic therapy is standard care for Barrett's esophagus patients with high-grade dysplasia or intramucosal adenocarcinoma. DNA content abnormality and treatment with EMR alone are significant risk factors for persistent/recurrent HGD/IMC or EAC, as identified through this study.
Article
Gastroenterology & Hepatology
Colin J. Ireland et al.
DIGESTIVE DISEASES AND SCIENCES
(2020)
Article
Biochemistry & Molecular Biology
Kai Li et al.
Review
Biology
Yuji Amano et al.
Review
Gastroenterology & Hepatology
David Steele et al.
WORLD JOURNAL OF GASTROENTEROLOGY
(2019)
Article
Biochemistry & Molecular Biology
Peng Jiang et al.
Article
Oncology
Thomas B. Nealis et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
(2011)
Article
Gastroenterology & Hepatology
Nelly E. Avissar et al.
JOURNAL OF GASTROINTESTINAL SURGERY
(2009)
Review
Gastroenterology & Hepatology
Rhonda F. Souza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
(2008)
Article
Oncology
Chia-Jui Yen et al.
Article
Gastroenterology & Hepatology
Francesca Milano et al.
